about
Disease monitoring in inflammatory bowel diseaseNormal response to vaccines in inflammatory bowel disease patients treated with thiopurinesIsolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon.Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance.Cutaneous Crohn's disease of the vulva.Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease: A Clinical Review.Objective structured clinical examination as a novel tool in inflammatory bowel disease fellowship education.Disruptive behavior in the workplace: Challenges for gastroenterology fellows.Using the Objective Structured Clinical Examination to Assess ACGME Competencies in Pediatric Gastroenterology Fellows.Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficileP-088 A Longitudinal OSCE ExperienceThe nocebo effect and patient perceptions of biosimilars in inflammatory bowel diseaseImproving handoff communication: a gastroenterology fellowship performance improvement projectIdentifying IBD Providers' Knowledge Gaps Using a Prospective Web-based SurveyA clinical and radiographic model to predict surgery for acute small bowel obstruction in Crohn's diseaseProposal to Update the Curriculum in Inflammatory Bowel Diseases for Categorical Gastroenterology Fellows
P50
Q26777553-840A2471-3276-453C-A2D0-3DF77FFF3861Q34173362-D17A25DB-8ADB-4F1B-A76B-EFCA0F84232EQ35577105-22DD60F1-1C65-4D1E-8438-EC0616FEF12EQ37542865-5B8C4D28-B954-4E5F-9259-12F6D1E82857Q37711839-40536CAB-C8A8-4DBD-89F0-3811690FB542Q38625896-5B6BB51E-33C1-4AC3-96E1-81A711FEE81EQ38657582-A6164A6A-0360-433E-A0C0-8CEAEB4BD7C2Q41509131-26AC6A2B-6A4C-445C-9F48-83C9223E13E1Q41909870-9B73552A-B1F1-4BD2-8E8D-A2C4CD9691E8Q50481890-577D2B56-DE8B-4517-AC19-DA0D0ACAF7C0Q57471148-04372421-DA46-482C-A598-4F8BBF010483Q59384698-F4CDF815-C64B-458F-A986-FE9988B5ACC0Q63447358-C670EF8D-75C7-47B6-A9F8-7F71BC873B22Q83131384-17430578-6196-4FE7-A09D-280C26AD88B0Q89886327-A14050E1-7D3B-40F9-BE50-19CBCB3E40DAQ91977060-DF414DB1-A788-4C0B-88C9-92FB80D30A74Q92208147-2DD2F64C-AC1F-428D-9D78-2AF7A408D117
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lisa B Malter
@ast
Lisa B Malter
@en
Lisa B Malter
@es
Lisa B Malter
@nl
Lisa B Malter
@sl
type
label
Lisa B Malter
@ast
Lisa B Malter
@en
Lisa B Malter
@es
Lisa B Malter
@nl
Lisa B Malter
@sl
prefLabel
Lisa B Malter
@ast
Lisa B Malter
@en
Lisa B Malter
@es
Lisa B Malter
@nl
Lisa B Malter
@sl
P106
P21
P31
P496
0000-0002-4026-5041